Metaverse Clinic for Pregnant Women With Subclinical Hypothyroidism
Study Overview
This study explores the use of a metaverse platform to help pregnant women with subclinical hypothyroidism (SCH), a common thyroid issue that can lead to problems during pregnancy.
Study Purpose
The goal is to check if the metaverse can safely and effectively manage SCH in pregnant women.
Study Method
Conducted at Fujian Provincial Hospital in China from July 2022 to December 2023, the study involved 60 pregnant women with SCH, split into two groups:
- Standard Group: 30 women received standard treatment.
- Metaverse Group: 30 women received standard treatment plus access to virtual medical consultations and engaging medical games in the metaverse.
Key Findings
- Maternal Outcomes: 43% of the standard group had adverse outcomes compared to 37% in the metaverse group.
- Offspring Outcomes: 33% in the standard group had adverse outcomes, while only 7% in the metaverse group.
- Mental Health Improvement: The metaverse group showed significant improvements in depression and anxiety levels.
Conclusion
The metaverse technology helped reduce adverse outcomes for babies and improved the mental health of mothers, while maternal health outcomes were similar in both groups.
Trial Registration
Registered at Chinese Clinical Trial Registry.
Value of Clinical Trials
Clinical trials are essential for developing safe treatments. Our platform, DocSym, streamlines clinical protocols and research, making it easy for clinicians to access information.
Practical Solutions for Healthcare
Our mobile apps simplify scheduling, treatment monitoring, and telemedicine, enhancing patient care and expanding digital services.
By leveraging AI, clinics can improve workflows and patient outcomes while reducing paperwork. Discover how we can assist you at aidevmd.com.
